HCV & HIV news from the Conference on Retroviruses and Opportunistic Infections (CROI)


Seattle_spm

Seattle Photo credit: spm. Wikipedia Commons

Here’s a conference we can all get behind–the helpful presentation and sharing of information on HIV, HCV, and retroviruses.

From Seattle, Business Wire press release Gilead has announced that patients co-infected with HCV genotypes 1-4 and HIV can achieve a 96 Percent SVR12 Rate taking the “daily single tablet regimen Harvoni.®”  

The Foundation that sponsors the annual conference has provided open access slides and audio available to learn from (LINK).  Available workshop topics available now include:

Acute HCV: Is It Still Important to Diagnose and Treat?

HCV Genotype 3: Our Next Challenge

HCV Cirrhotics With Early Decompensation 

Ear_Headphones

Image: wikipedia Commons, PD.

To hear or see up-to-date information from the experts, just type in HCV in the search box and stream. Podcasts of talks are also available for downloads using Apple’s iTunes.  iTunes can be downloaded free to newer computers running Windows.  Apps can help move files to Android phones according to an article in Android Central here: (LINK) if you don’t own an iPhone.

For more information on Harvoni, please visit HCVETS here: (LINK).

This entry was posted in Guest authors, HCV Health, HCV Risks (documented), Sofosbuvir and tagged , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s